Edesa Biotech Inc (EDSA)

$7.47 -0.48 (-6.04%)
Market Cap 70.69M
Revenue (ttm) 0.00
Net Income (ttm) -7.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 130,200
Avg Vol 608,406
Day's Range N/A - N/A
Shares Out 8.89M
Stochastic %K 70%
Beta 1.03
Analysts Strong Sell
Price Target $11.00

Company Profile

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. It develops EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic aller...

Industry: Biotechnology
Sector: Healthcare
Phone: 289 800 9600
Address:
100 Spy Court, Markham, Canada
Treb3k
Treb3k Jun. 24 at 9:59 PM
$EDSA follow my discord
0 · Reply
Treb3k
Treb3k Jun. 24 at 9:56 PM
$EDSA this was in 2015: https://gildehealthcare.com/news/venture-and-growth/am-pharma-signs-600-million-acquisition-option-with-pfizer/
0 · Reply
Boywithathorn
Boywithathorn Jun. 24 at 6:15 PM
$EDSA what’s interesting $8 dosent excite us ole school investors. Neither does $10. Now $15-20 is pretty cool. But we want $30-$50!
2 · Reply
Rmank47
Rmank47 Jun. 24 at 4:21 PM
$EDSA 👏👏👏
0 · Reply
Rmank47
Rmank47 Jun. 24 at 4:14 PM
$EDSA hold on…hooooooold on to 8$!
0 · Reply
Rmank47
Rmank47 Jun. 24 at 4:02 PM
$EDSA
0 · Reply
Boywithathorn
Boywithathorn Jun. 24 at 12:33 AM
$EDSA you tech guys. We aren’t looking and building the right shoulder on a head n shoulders pattern are we? I sure hope not.
0 · Reply
Boywithathorn
Boywithathorn Jun. 24 at 12:00 AM
$EDSA it’s coming. It’s called the tripling.
0 · Reply
EireTrader
EireTrader Jun. 23 at 7:26 PM
$EDSA ...Shorty
1 · Reply
Moneyybaggs
Moneyybaggs Jun. 23 at 2:41 PM
$EDSA @EdV3, are you buying back in at these levels Eddie?
0 · Reply
Latest News on EDSA
Edesa Biotech announces $3.5M private placement

2026-06-11T13:27:38.000Z - 14 days ago

Edesa Biotech announces $3.5M private placement

Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors

Jun 11, 2026, 9:15 AM EDT - 14 days ago

Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors

Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury

Jun 5, 2026, 9:20 AM EDT - 20 days ago

Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury

Edesa Biotech Inc trading resumes

2026-05-19T13:40:50.000Z - 5 weeks ago

Edesa Biotech Inc trading resumes

Edesa Biotech Inc trading halted, volatility trading pause

2026-05-19T13:35:48.000Z - 5 weeks ago

Edesa Biotech Inc trading halted, volatility trading pause

Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference

May 19, 2026, 9:15 AM EDT - 5 weeks ago

Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference

Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results

May 14, 2026, 4:30 PM EDT - 6 weeks ago

Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results

Edesa Biotech Inc trading halted, volatility trading pause

2026-04-28T14:26:55.000Z - 2 months ago

Edesa Biotech Inc trading halted, volatility trading pause

Edesa Biotech Inc trading resumes

2026-04-28T14:20:13.000Z - 2 months ago

Edesa Biotech Inc trading resumes

Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit

Mar 31, 2026, 4:20 PM EDT - 3 months ago

Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit

Edesa Biotech provides update on EB06 clinical study

2026-03-26T13:37:21.000Z - 3 months ago

Edesa Biotech provides update on EB06 clinical study

Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment

Mar 26, 2026, 9:15 AM EDT - 3 months ago

Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment

Edesa Biotech reports additional results from Phase 3 paridiprubart study

2026-02-24T14:20:13.000Z - 4 months ago

Edesa Biotech reports additional results from Phase 3 paridiprubart study

Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study

Feb 24, 2026, 9:15 AM EST - 4 months ago

Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study

Edesa Biotech reports Q1 EPS (28c), consensus (45c)

2026-02-13T21:25:18.000Z - 4 months ago

Edesa Biotech reports Q1 EPS (28c), consensus (45c)

Edesa Biotech Reports Fiscal 1st Quarter 2026 Results

Feb 13, 2026, 4:20 PM EST - 4 months ago

Edesa Biotech Reports Fiscal 1st Quarter 2026 Results

Edesa Biotech Reports Fiscal Year 2025 Results

Dec 12, 2025, 4:20 PM EST - 6 months ago

Edesa Biotech Reports Fiscal Year 2025 Results

Edesa Biotech Announces Upcoming Conference Schedule

Oct 31, 2025, 4:30 PM EDT - 8 months ago

Edesa Biotech Announces Upcoming Conference Schedule

Edesa Biotech announces Phase 3 study of paridiprubart met primary endpoint

2025-10-28T11:55:48.000Z - 8 months ago

Edesa Biotech announces Phase 3 study of paridiprubart met primary endpoint

Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study

Oct 28, 2025, 7:45 AM EDT - 8 months ago

Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

Aug 8, 2025, 4:35 PM EDT - 11 months ago

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

Edesa Biotech files $150M mixed securities shelf

2025-07-25T20:50:18.000Z - 11 months ago

Edesa Biotech files $150M mixed securities shelf

Edesa Biotech assumed with a Buy at H.C. Wainwright

2025-06-27T14:35:08.000Z - 1 year ago

Edesa Biotech assumed with a Buy at H.C. Wainwright

Edesa Biotech initiated with a Buy at Lucid Capital

2025-05-23T10:55:53.000Z - 1 year ago

Edesa Biotech initiated with a Buy at Lucid Capital

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

May 14, 2025, 4:15 PM EDT - 1 year ago

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

Apr 28, 2025, 4:30 PM EDT - 1 year ago

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

Edesa Biotech says Peter Weiler to succeed Stephen Lemieux as CFO

2025-04-04T20:20:09.000Z - 1 year ago

Edesa Biotech says Peter Weiler to succeed Stephen Lemieux as CFO

Edesa Biotech Announces Chief Financial Officer Transition

Apr 4, 2025, 4:15 PM EDT - 1 year ago

Edesa Biotech Announces Chief Financial Officer Transition

Edesa Biotech files to sell 7.81M common shares for holders

2025-03-04T21:36:26.000Z - 1 year ago

Edesa Biotech files to sell 7.81M common shares for holders

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

Feb 14, 2025, 4:15 PM EST - 1 year ago

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results

Edesa Biotech announces $15M private placement priced at-the-market

2025-02-13T12:55:07.000Z - 1 year ago

Edesa Biotech announces $15M private placement priced at-the-market

Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Feb 13, 2025, 7:00 AM EST - 1 year ago

Edesa Biotech Announces $15.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Edesa Biotech Reports Fiscal Year 2024 Results

Dec 13, 2024, 4:30 PM EST - 1 year ago

Edesa Biotech Reports Fiscal Year 2024 Results

Edesa Biotech founder Par Nijhawan to invest up to $5M in company

2024-10-31T12:33:18.000Z - 1 year ago

Edesa Biotech founder Par Nijhawan to invest up to $5M in company

Edesa Biotech's Founder Makes Strategic Investment in the Company

Oct 31, 2024, 8:15 AM EDT - 1 year ago

Edesa Biotech's Founder Makes Strategic Investment in the Company

Pardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc.

Sep 13, 2024, 7:38 PM EDT - 1 year ago

Pardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc.

Edesa Biotech reports Q3 EPS (52c) vs (68c) last year

2024-08-09T20:21:43.000Z - 2 years ago

Edesa Biotech reports Q3 EPS (52c) vs (68c) last year

Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results

Aug 9, 2024, 4:20 PM EDT - 2 years ago

Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results

BARDA selects Edesa Biotech drug for U.S. funded platform trial in ARDS

2024-06-24T12:58:43.000Z - 2 years ago

BARDA selects Edesa Biotech drug for U.S. funded platform trial in ARDS

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

Jun 24, 2024, 8:20 AM EDT - 2 years ago

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

May 10, 2024, 4:15 PM EDT - 2 years ago

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

Edesa Biotech to Participate in Upcoming Investor Conferences

Apr 2, 2024, 9:00 AM EDT - 2 years ago

Edesa Biotech to Participate in Upcoming Investor Conferences

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference

Mar 21, 2024, 4:30 PM EDT - 2 years ago

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference

Edesa Biotech to Participate in Barclays Global Healthcare Conference

Mar 7, 2024, 8:45 AM EST - 2 years ago

Edesa Biotech to Participate in Barclays Global Healthcare Conference

Edesa Biotech to Participate in Upcoming Dermatology Meetings

Mar 4, 2024, 4:30 PM EST - 2 years ago

Edesa Biotech to Participate in Upcoming Dermatology Meetings

Edesa Biotech Reports Fiscal 1st Quarter 2024 Results

Feb 9, 2024, 4:15 PM EST - 2 years ago

Edesa Biotech Reports Fiscal 1st Quarter 2024 Results

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

Jan 4, 2024, 4:15 PM EST - 2 years ago

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

Edesa Biotech Reports Fiscal Year 2023 Results

Dec 15, 2023, 4:10 PM EST - 2 years ago

Edesa Biotech Reports Fiscal Year 2023 Results

Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study

Nov 20, 2023, 4:05 PM EST - 2 years ago

Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study

Edesa Biotech to Present at Dermatology Drug Development Summit

Oct 26, 2023, 4:05 PM EDT - 2 years ago

Edesa Biotech to Present at Dermatology Drug Development Summit

Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech's ARDS Drug

Oct 25, 2023, 9:10 AM EDT - 2 years ago

Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech's ARDS Drug

Edesa Biotech Secures $10 Million Credit Facility with Company Founder

Oct 12, 2023, 12:15 PM EDT - 2 years ago

Edesa Biotech Secures $10 Million Credit Facility with Company Founder

Edesa Biotech to Receive Up To C$23 Million in Funding from Federal Government

Oct 12, 2023, 12:10 PM EDT - 2 years ago

Edesa Biotech to Receive Up To C$23 Million in Funding from Federal Government

Edesa Biotech Announces One-for-Seven Reverse Share Split

Oct 10, 2023, 9:00 AM EDT - 2 years ago

Edesa Biotech Announces One-for-Seven Reverse Share Split

Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate

Sep 28, 2023, 8:15 AM EDT - 2 years ago

Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate

Edesa Biotech Reports Fiscal Third Quarter 2023 Results

Aug 9, 2023, 4:15 PM EDT - 3 years ago

Edesa Biotech Reports Fiscal Third Quarter 2023 Results

Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference

Jul 26, 2023, 9:00 AM EDT - 3 years ago

Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference

Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens

Jun 28, 2023, 7:55 AM EDT - 3 years ago

Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens

Edesa Biotech Appoints Biotech Deal Veteran to CFO Role

Jun 27, 2023, 8:15 AM EDT - 3 years ago

Edesa Biotech Appoints Biotech Deal Veteran to CFO Role

Edesa Biotech Anti-Inflammatory Drug Candidate Assigned Name

Jun 15, 2023, 8:00 AM EDT - 3 years ago

Edesa Biotech Anti-Inflammatory Drug Candidate Assigned Name

Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results

May 11, 2023, 4:30 PM EDT - 3 years ago

Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results

Edesa Biotech to Participate in Swiss Biotech Day

Apr 20, 2023, 8:30 AM EDT - 3 years ago

Edesa Biotech to Participate in Swiss Biotech Day

The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate

Apr 4, 2023, 8:45 AM EDT - 3 years ago

The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conference

Mar 23, 2023, 4:30 PM EDT - 3 years ago

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conference

Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting

Mar 16, 2023, 4:10 PM EDT - 3 years ago

Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting

Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study

Mar 15, 2023, 8:10 AM EDT - 3 years ago

Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study

Edesa Biotech Reports Fiscal 1st Quarter 2023 Results

Feb 10, 2023, 9:00 AM EST - 3 years ago

Edesa Biotech Reports Fiscal 1st Quarter 2023 Results

Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study

Feb 1, 2023, 8:15 AM EST - 3 years ago

Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study

Treb3k
Treb3k Jun. 24 at 9:59 PM
$EDSA follow my discord
0 · Reply
Treb3k
Treb3k Jun. 24 at 9:56 PM
$EDSA this was in 2015: https://gildehealthcare.com/news/venture-and-growth/am-pharma-signs-600-million-acquisition-option-with-pfizer/
0 · Reply
Boywithathorn
Boywithathorn Jun. 24 at 6:15 PM
$EDSA what’s interesting $8 dosent excite us ole school investors. Neither does $10. Now $15-20 is pretty cool. But we want $30-$50!
2 · Reply
Rmank47
Rmank47 Jun. 24 at 4:21 PM
$EDSA 👏👏👏
0 · Reply
Rmank47
Rmank47 Jun. 24 at 4:14 PM
$EDSA hold on…hooooooold on to 8$!
0 · Reply
Rmank47
Rmank47 Jun. 24 at 4:02 PM
$EDSA
0 · Reply
Boywithathorn
Boywithathorn Jun. 24 at 12:33 AM
$EDSA you tech guys. We aren’t looking and building the right shoulder on a head n shoulders pattern are we? I sure hope not.
0 · Reply
Boywithathorn
Boywithathorn Jun. 24 at 12:00 AM
$EDSA it’s coming. It’s called the tripling.
0 · Reply
EireTrader
EireTrader Jun. 23 at 7:26 PM
$EDSA ...Shorty
1 · Reply
Moneyybaggs
Moneyybaggs Jun. 23 at 2:41 PM
$EDSA @EdV3, are you buying back in at these levels Eddie?
0 · Reply
RKLBupupup
RKLBupupup Jun. 23 at 12:54 PM
$EDSA $6.37
0 · Reply
RKLBupupup
RKLBupupup Jun. 23 at 10:59 AM
$EDSA $6.54!!
0 · Reply
Boywithathorn
Boywithathorn Jun. 22 at 7:05 PM
$EDSA we can’t get upset with the low volume drops or too excited with the low volume pops. What I can say it 100% this mf is doubling and will surpass the yearly high months to come. Par really pulled it off. This is a goldmine.
0 · Reply
History101
History101 Jun. 22 at 7:02 PM
$EDSA $7!!
1 · Reply
Treb3k
Treb3k Jun. 22 at 1:39 AM
$EDSA chat GPT giving all bots the same stuff to post up in here
0 · Reply
Boywithathorn
Boywithathorn Jun. 20 at 10:20 PM
$EDSA soon will be Edesa. https://investors.biogen.com/news-releases/news-release-details/biogen-expands-immunology-pipeline-agreement-acquire-raythera
0 · Reply
MadStockAlerts1
MadStockAlerts1 Jun. 20 at 7:11 PM
$EDSA isn't making noise, and that's what's interesting. The MACD just crossed bullish on the daily, the kind of quiet shift the big boys notice while everyone else looks away. The least dramatic moves are often the ones worth watching 🔥
0 · Reply
topstockalerts
topstockalerts Jun. 20 at 1:32 AM
$EDSA sometimes the best moves are the least dramatic.
0 · Reply
EireTrader
EireTrader Jun. 19 at 11:31 PM
$EDSA .. Annoucement to kick off Bio Convention. Not that wild a thought
1 · Reply
Boywithathorn
Boywithathorn Jun. 19 at 5:20 PM
$EDSA so huge. To me this guy is bigger than Cohen and Elderman. https://www.stocktitan.net/sec-filings/EDSA/schedule-13g-edesa-biotech-inc-passive-investment-disclosure-5-2150c1c98f1d.html
1 · Reply
GaryMelon
GaryMelon Jun. 19 at 3:25 PM
$EDSA They cleaned up the balance sheet for a month or two with that PIPE. Perfect window for negotiations. Expecting a single indication out-licensing deal by October 🤞
1 · Reply
EDSA2Chap11
EDSA2Chap11 Jun. 19 at 6:03 AM
$EDSA Anyway… where was I… oh, yes… Did we ever decide where the Yacht party was going to be? Canada, US or Ireland? Ah, so many longs gone. Some great characters, and by great characters I mean completely fucking bonkers. But, you know, in a good way. BFL
3 · Reply